Separated T cell receptor, cells modified by separated T cell receptor, encoding nucleic acid, expression vector, preparation method, pharmaceutical composition and application
A cell receptor and nucleic acid technology, applied in the biological field, to avoid immune rejection, good industrial application prospects, and avoid cytokine storms
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0139] Preparation of recombinant TCR lentiviral expression vector: the viral vector used to express TCR is a replication-defective lentiviral vector, including: the lentiviral vector pCDH-EF1α-MCS-(PGK-GFP) expressing GFP, which can be purchased from System Biosciences (Cat#CD811A-1); and the vector pCDH-EF1α-MCS that does not express GFP, obtained by removing the PGK promoter and GFP gene on the pCDH-EF1α-MCS-(PGK-GFP) vector by using conventional techniques in the art. According to the obtained TCR gene sequence, synthesize the whole gene sequence of TCR β chain and α chain and the cleavable F2A sequence and Furin restriction fragment between them, and link to the multiple cloning site downstream of the EF-1α promoter of the vector , the sequence of transcription inserted into TCR is TCRβ chain (without stop codon), Furin fragment, F2A fragment, and TCRα chain (see the literature "Gene Ther. 2008 Nov; 15(21): 1411-1423"). The vector expressing GFP is driven by the inverted ...
Embodiment 1
[0142] Example 1: Induction of Her2 / neu 369-377 polypeptide-specific killer T cells from HLA-A2 positive normal donor peripheral blood
[0143] In this example, a low-concentration Her2 / neu 369-377 polypeptide of 1 μg / ml was used to induce polypeptide-specific killer T cells from normal PBMC (#2PBMC) after two rounds of in vitro stimulation, and flow cytometry analysis and single cell isolation were performed. The specific method is as described above. The result is as follows:
[0144] figure 1 A The right figure shows that 0.013% of lymphocytes are CD8-positive killer T cells that can bind to Her2 / neu 369-377 / HLA-A2 pentamer (ie Her2-E75 pentamer), and the left figure is not stimulated by Her2 polypeptide There were no CD8-positive pentamer-positive cells in the control cells. The results showed that in the natural T cell pool, the number of specific T cells recognizing Her2 / neu 369-377 antigen polypeptide was very small. Although small in number, this group of T cells t...
Embodiment 2
[0145] Example 2: Obtaining and identifying the complete sequence of Her2 / neu 369-377 polypeptide-specific TCR
[0146] In this example, the Her2 / neu 369-377 polypeptide-specific CTL clone obtained in Example 1 is directly obtained from the Her2 / neu 369-377 polypeptide-specific CTL clone comprising matching α and β chains (that is, the two chains can together form a functional TCR that recognizes the antigen polypeptide). The complete TCR gene sequence, the encoded TCR is called "Her2 TCR-1B5". The amino acid sequence of the α chain of the TCR is shown in SEQ ID NO: 2, the coding sequence is shown in SEQ ID NO: 1, and the amino acid sequence of the β chain of the TCR is shown in SEQ ID NO: 4, and the coding sequence is shown in SEQ ID NO: 4. ID NO:3 shown. This TCR exists in the peripheral T cell pool of HLA-A2 positive normal people, and will not cross-react with normal cells that express Her2 / neu protein in a small amount and cause autoimmune reactions. The specific detect...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com